Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Aurinia Pharm Ord (NQ: AUPH )

23.55 USD +0.31 (+1.33%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 27, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,934,102
Open 23.36
Bid (Size) 23.05 (1)
Ask (Size) 23.55 (1)
Prev. Close 23.24
Today's Range 22.95 - 23.79
52wk Range 9.720 - 24.18
Shares Outstanding 128,395,927
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Aurinia Pharmaceuticals to Present at Upcoming September Investor Conferences
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (the “Company”) today announced that members of the senior management team will present at the following upcoming virtual investor conferences: 
From Business Wire News Releases
Best Stocks To Invest In Right Now? 4 Health Care Stocks To Know
Tags Market News
From StockMarket.com

Performance

YTD
+73.93%
+73.93%
1 Month
+38.37%
+38.37%
3 Month
+72.78%
+72.78%
6 Month
+90.69%
+90.69%
1 Year
+64.00%
+64.00%

More News

Read More
Aurinia Pharmaceuticals to Participate in H.C. Wainwright 23rd Annual Global Investment Conference
From Business Wire News Releases
First Week of AUPH January 2024 Options Trading
Tags Stocks
From Market News Video
2 Best Biotech Stocks to Buy Right Now
Tags Market News AUPH AXSM
From Motley Fool
Aurinia Acquires Novel Pipeline Assets Targeting Autoimmune and Kidney-related Diseases
From Business Wire News Releases
Pharma, Tech and Finance
Tags Technology Healthcare Pharma/Biotech
From TalkMarkets
Sunday Special
Tags Stocks / Equities Market News
From TalkMarkets
Stocks To Watch: Aurinia Pharmaceuticals Sees Relative Strength Rating Jump To 92
From Investor's Business Daily
Post-Rosh Hashanah, Sell?
Tags Stocks / Equities Market News
From TalkMarkets
Aurinia Adds Two Assets To Expand Its Immunology Pipeline
Tags Market News M&A autoimmune diseases
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.